Trials / Completed
CompletedNCT06338761
Switching to E-cigarette After PCI
Prognostic Impact of Switching to E-Cigarette Use in Smokers With Coronary Artery Disease Following Percutaneous Coronary Intervention: A Nationwide Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 17,973 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Despite the increasing popularity of electronic cigarettes (E-cigarettes), the prognostic impact of switching to E-cigarettes in smokers with coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI) remains uncertain.
Detailed description
Recently, several studies have reported that, although lower than combustible cigarette users, E-cigarette users had a significantly higher risk of future myocardial infarction (MI) or cardiovascular disease compared with non-smokers or quitters. However, because all previous studies has focused on the general healthy population, these results cannot be extrapolated for patients who already proven atherosclerotic cardiovascular disease (ASCVD), such as undergoing percutaneous coronary intervention (PCI) for coronary artery disease (CAD). Although Busch et al. previously reported that a significant minority of patients are using E-cigarettes post-acute coronary syndrome smokers, a paucity of data exists regarding the impact of such transitions on clinical outcomes in current smoker patients with CAD who have undergone PCI. In light of these considerations, the current study sought to address this gap in knowledge by evaluating the prognostic implications of smoking habit changes, including E-cigarette use, among CAD patients with current smoking status following PCI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Smoking cessation | Stop smoking |
| BEHAVIORAL | Switching to E-cigarette | Switching to E-cigarette |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-12-31
- Completion
- 2025-03-15
- First posted
- 2024-04-01
- Last updated
- 2025-05-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06338761. Inclusion in this directory is not an endorsement.